Delta Electronics (Thailand) PCL (BKK:DELTA)

CTI BioPharma Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12,967	15,701	7,617	10,142	6,572	13,882
Cash & Short-Term Investments	12,967	15,701	7,617	10,142	6,572	13,882
Cash Growth	110.99%	106.12%	-24.90%	54.34%	-52.66%	11.01%
Accounts Receivable	37,685	31,975	32,029	27,292	19,787	13,131
Other Receivables	2,403	2,085	1,811	1,291	1,280	1,224
Receivables	40,088	34,061	33,841	28,584	21,068	14,355
Inventory	32,947	31,697	32,747	25,049	19,581	12,655
Prepaid Expenses	859	855	451	305	245	297
Other Current Assets	708.79	217.66	910.67	1,946	944.39	1,262
Total Current Assets	87,570	82,532	75,566	66,025	48,409	42,452
Property, Plant & Equipment	42,632	38,186	30,207	23,182	19,113	13,101
Long-Term Investments	1.55	0.77	-	-	-	-
Goodwill	424.47	433.69	443.89	436.62	443.05	436.91
Other Intangible Assets	121.87	137.78	147.21	192.08	249.8	495.96
Long-Term Deferred Tax Assets	705.86	591.11	436.27	320.2	347.61	289.01
Other Long-Term Assets	1,257	1,216	1,345	828.68	776.13	444.21
Total Assets	132,713	123,097	108,145	90,984	69,338	57,219
Accounts Payable	27,659	25,434	20,328	20,142	14,011	11,312
Accrued Expenses	6,179	3,828	3,805	4,195	3,960	2,739
Short-Term Debt	101	160.2	2,497	945.28	1,594	-
Current Portion of Leases	86.64	84.83	110.25	66.06	74.96	72.79
Current Income Taxes Payable	467.12	334.56	563.54	423.45	124.67	188.7
Other Current Liabilities	8,595	8,285	8,872	6,898	4,971	2,858
Total Current Liabilities	43,418	38,127	36,176	32,670	24,736	17,170
Long-Term Debt	839.95	1,088	825.3	794.57	367.57	-
Long-Term Leases	133.07	123.47	144.13	135.84	144.12	107.79
Long-Term Deferred Tax Liabilities	367.84	386.42	233.77	139.02	130.7	114.18
Other Long-Term Liabilities	2,283	1,871	1,649	1,236	960.2	676.91
Total Liabilities	48,697	43,155	40,606	36,305	27,934	19,611
Common Stock	1,247	1,247	1,247	1,247	1,247	1,247
Additional Paid-In Capital	1,492	1,492	1,492	1,492	1,492	1,492
Retained Earnings	86,340	81,961	68,626	55,391	41,902	39,342
Comprehensive Income & Other	-5,064	-4,758	-3,826	-3,450	-3,237	-4,470
Total Common Equity	84,015	79,942	67,539	54,680	41,404	37,612
Minority Interest	-	-	-	-	-	-4.31
Shareholders' Equity	84,015	79,942	67,539	54,680	41,404	37,607
Total Liabilities & Equity	132,713	123,097	108,145	90,984	69,338	57,219
Total Debt	1,492	1,456	3,576	1,942	2,180	180.58
Net Cash (Debt)	11,475	14,245	4,041	8,200	4,391	13,701
Net Cash Growth	178.64%	252.51%	-50.72%	86.75%	-67.95%	9.56%
Net Cash Per Share	0.92	1.14	0.32	0.66	0.35	1.10
Filing Date Shares Outstanding	12,474	12,474	12,474	12,474	12,474	12,474
Total Common Shares Outstanding	12,474	12,474	12,474	12,474	12,474	12,474
Working Capital	44,152	44,405	39,390	33,356	23,673	25,281
Book Value Per Share	6.74	6.41	5.41	4.38	3.32	3.02
Tangible Book Value	83,469	79,370	66,947	54,051	40,711	36,679
Tangible Book Value Per Share	6.69	6.36	5.37	4.33	3.26	2.94
Land	-	2,182	1,805	1,789	1,743	1,020
Buildings	-	11,966	7,977	5,028	4,758	3,975
Machinery	-	39,144	30,399	23,334	18,610	14,563
Construction In Progress	-	7,162	7,118	7,005	5,901	3,822

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.